Treatment typically starts with a lower dose (0.25 mg weekly for 4 weeks), which is then increased to 0.5 mg, with further increases to 1 mg or 2 mg if needed for glycaemic control
The microdosed tirzepatide FAQ states that your dose can be increased "anytime if clinical fit changes," and that the brand "can also transition you onto full-dose Tirzepatide without restarting the intake." The semaglutide FAQ separately references head-to-head clinical-trial context for tirzepatide versus semaglutide - this article treats that as drug-class research context, not as clinical validation of Telos Rx's compounded formulations specifically
All programs include in clinic nurse administration and support, physician supervised program, clinical dosing and titration management, monthly advanced InBody scans, high quality GLP (Third party tested for purity, sterility, and contaminants)
Personalized Dosing Strategies in Practice Microdosing strategies have become a pivotal aspect of personalized medicine, especially with the use of click-counting methods in multi-dose pens, which offer a level of flexibility that is crucial for tailoring GLP-1 dosing to individual patient needs